CME Group Inc. (NASDAQ:CME) Shares Acquired by Pacer Advisors Inc.

Pacer Advisors Inc. boosted its holdings in CME Group Inc. (NASDAQ:CME) by 27.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,508 shares of the financial services provider’s stock after purchasing an additional 9,905 shares during the quarter. Pacer Advisors Inc.’s holdings in CME Group were worth $10,262,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA increased its position in CME Group by 18.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,826,501 shares of the financial services provider’s stock worth $403,017,000 after purchasing an additional 283,171 shares during the last quarter. America First Investment Advisors LLC increased its holdings in shares of CME Group by 2.2% during the 3rd quarter. America First Investment Advisors LLC now owns 97,902 shares of the financial services provider’s stock worth $21,602,000 after buying an additional 2,122 shares during the last quarter. Cypress Capital Group raised its position in shares of CME Group by 1.1% in the 3rd quarter. Cypress Capital Group now owns 34,190 shares of the financial services provider’s stock worth $7,544,000 after buying an additional 373 shares during the period. Primecap Management Co. CA boosted its holdings in CME Group by 3.3% in the third quarter. Primecap Management Co. CA now owns 1,861,690 shares of the financial services provider’s stock valued at $410,782,000 after acquiring an additional 58,647 shares during the last quarter. Finally, Intech Investment Management LLC grew its position in CME Group by 46.2% during the third quarter. Intech Investment Management LLC now owns 22,830 shares of the financial services provider’s stock valued at $5,037,000 after acquiring an additional 7,214 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Trading Up 1.1 %

NASDAQ:CME opened at $229.04 on Friday. The stock has a market cap of $82.54 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 5.23 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50-day simple moving average is $223.64 and its 200 day simple moving average is $211.09.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the company posted $2.25 EPS. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.01%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

Insider Transactions at CME Group

In other news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,621 shares of company stock valued at $3,441,063. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several research analyst reports. The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Oppenheimer increased their price objective on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Finally, Bank of America increased their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.